Volume 11, Number 10, October 2005

Antibacterial Cleaning Products and Drug Resistance

Allison E. Aiello,* Bonnie Marshall,† Stuart B. Levy,† Phyllis Della-Latta,‡ Susan X. Lin,‡ and Elaine Larson‡
*University of Michigan School of Public Health, Ann Arbor, Michigan, USA; †Tufts University School of Medicine, Boston, Massachusetts, USA; and ‡Columbia University, New York, New York, USA

Appendix Figure. Proportion of study participants with gram-negative bacteria resistant to antimicrobial agents, methicillin-resistant Staphylococcus aureus (MRSA), and methicillin-resistant, coagulase-negative staphylococci (MRCNS). For A and B, Acinetobacter baumanii and A. lwoffi were combined to represent Acinetobacter spp. For C and D, Enterobacter cloacae and E. agglomerans were combined to represent Enterobacter spp. IPM, imipenem; GEN, gentamicin; CIP, ciprofloxacin; AMK, amikacin; CAZ, ceftazidime; TIM, ticarcillin-clavulanic acid; SXT, trimethoprim-sulfamethoxazole; CRO, ceftriaxone; TZP, piperacillin-tazobactam.

EID Home | Top of Page | Ahead-of-Print | Past Issues | Suggested Citation | EID Search | Contact Us | Accessibility | Privacy Policy Notice | CDC Home | CDC Search | Health Topics A-Z

This page last reviewed August 25, 2005

Emerging Infectious Diseases Journal
National Center for Infectious Diseases
Centers for Disease Control and Prevention